VivoSphere
VivoSphere™ is pioneering advancements in drug discovery and toxicity testing through cutting-edge tissue engineering technologies. Specializing in human 3D disease models, we create physiologically relevant environments that enhance the accuracy and predictability of in vitro studies. Our expertise spans 3D cell culture, oncology research, and high-throughput screening, offering innovative solutions that replicate complex tissue microenvironments. By integrating high cell density encapsulation and assay-ready 3D tissues, we provide researchers with more reliable and translatable data for drug development. With a commitment to scientific excellence and innovation, we strive to improve preclinical testing processes, accelerating the development of safer and more effective therapeutics.
Industries
Nr. of Employees
small (1-50)
VivoSphere
540 Devall Dr, Auburn, AL 36832, USA
Products
3D cell culture models
Physiologically relevant three-dimensional cell culture constructs designed to replicate native tissue interactions for drug discovery and disease modeling.
Assay-ready 3D tissues
Pre-validated, plate-format tissue constructs provided in HTS-compatible formats for automated drug screening and toxicity testing.
Customized 3D tissue constructs and microspheres
Custom hydrogel-encapsulated, cell-laden microspheres and tissue constructs produced via microfluidic encapsulation for research and regenerative applications.
3D cell culture models
Physiologically relevant three-dimensional cell culture constructs designed to replicate native tissue interactions for drug discovery and disease modeling.
Assay-ready 3D tissues
Pre-validated, plate-format tissue constructs provided in HTS-compatible formats for automated drug screening and toxicity testing.
Customized 3D tissue constructs and microspheres
Custom hydrogel-encapsulated, cell-laden microspheres and tissue constructs produced via microfluidic encapsulation for research and regenerative applications.
Services
Collaborative development of tailored 3D tissue constructs and microenvironments to meet specific research objectives across oncology, toxicology, and regenerative medicine.
Provision of pre-validated, automation-compatible 3D tissue formats designed for integration with HTS platforms and automated workflows.
Collaborative research partnerships to co-develop models, validate applications, and translate in vitro findings toward preclinical objectives.
Support for integrating 3D tissue models into automated screening pipelines, including plate-format optimization and assay workflow alignment.
Collaborative development of tailored 3D tissue constructs and microenvironments to meet specific research objectives across oncology, toxicology, and regenerative medicine.
Provision of pre-validated, automation-compatible 3D tissue formats designed for integration with HTS platforms and automated workflows.
Collaborative research partnerships to co-develop models, validate applications, and translate in vitro findings toward preclinical objectives.
Support for integrating 3D tissue models into automated screening pipelines, including plate-format optimization and assay workflow alignment.
Expertise Areas
- 3D tissue engineering
- High-throughput screening for drug discovery
- Oncology disease modeling
- In vitro toxicology testing
Key Technologies
- 3D cell culture
- Hydrogel biomaterials
- Droplet microfluidics
- Microsphere encapsulation